The burden of cervical cancer in China: Synthesis of the evidence
Tóm tắt
The burden of cervical cancer in China has not been characterized in detail. We reviewed cervical cancer data from national mortality surveys and registries, and conducted a meta‐analysis to estimate the prevalence of high‐grade lesions (HSIL) and high‐risk human papillomavirus (HR‐HPV) infections in rural Shanxi Province. We found that a national survey in the 1970s estimated age‐standardized cervical cancer mortality rates as ∼15 and ∼83/100,000 women nationally and in Xiangyuan, Shanxi; but the latest survey (2004–2005) found much lower rates of ∼3 and ∼7/100,000, respectively. IARC registries record age‐standardized cervical cancer incidence in China as <5/100,000 (1998–2002); but the five registry sites cover <2% of the population, and the gross domestic product per capita at each of the registry sites is higher than China's average (by a factor ranging from 1.3 to 3.9). The pooled estimate of the prevalence of HSIL and HR‐HPV in women aged 30–54 years in Shanxi was 3.7%(95%CI:2.7–4.8%) and 17.2%(95%CI:13.1–21.3%), respectively. Based on a feasible range informed by the incidence data for China and other unscreened populations, the predicted indicative annual number of new cervical cancer cases nationally, in the absence of any intervention, ranges from ∼27,000 to 130,000 (2010) to 42,000 to 187,000 (2050). In conclusion, recent data suggest comparatively low rates of cervical cancer incidence in China, which may be partly explained by the location of registry sites in higher socioeconomic status areas. However, the evidence is consistent with considerable heterogeneity within China, with a higher disease burden in some rural areas such as Shanxi. Therefore, the lower reported rates of cervical cancer in China should be interpreted cautiously.
Từ khóa
Tài liệu tham khảo
Ferlay J, 2010, GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10
National Office for Cancer Prevention and Control of Chinese Ministry of Health, 1979, Investigate for malignant tumour mortality in China
1979, National Office for Cancer Prevention and Control of Chinese Ministry of Health
National Office for Cancer Prevention and Control of Chinese Ministry of Health, 2008, Investigate for malignant tumour mortality in China (1990–1992)
Chen Z, 2008, The Third National Retrospective Sampling Death Survey
Statistics websites of Chinese central and local governments. Population data and the GDP per capita in China. Available athttp://www.stats.gov.cn/. 20–9‐2010.
Zhao FH, 2009, Association between high‐risk human papillomavirus DNA load and different histological grades of cervical neoplasia, Zhonghua Yu Fang Yi Xue Za Zhi, 43, 565
Bao YP, 2007, The study of human papillomavirus (HPV) type‐distribution in cervix of women from Yangcheng County, Shanxi Province and Meta‐analysis of HPV Type‐distribution in cervix of women in China and Asia
International Agency for Research on Cancer. WHO mortality database extracted from the World Health Organization (WHO) Databank. 2005. Available athttp://www‐dep.iarc.fr/(accessed on 1‐10‐2010).
Parkin DM, 2002
Curado MP, 2007
Yang L, 2003, Sources of information on the burden of cancer in China, Asian Pacific J Cancer Prev, 4, 23
Zhang SW, 2006, An analysis of cancer incidence and mortality from 30 cancer registries in China, 1998–2002, Bull Chin Cancer, 15, 439
Chen WQ, 2009, Estimation of cancer incidence and mortality in China in 2004–2005, Zhonghua Zhong Liu Za Zhi, 31, 664
Zhang SW, 2007, An annual report: cancer incidence in 35 cancer registries in China, 2003, Bull Chin Cancer, 16, 494
Chen WQ, 2007, An annual report: cancer mortality in 35 cancer registries in China, 2003, Bull Chin Cancer, 16, 586
Zhang SW, 2008, A report of cancer incidence from 37 cancer registries in China, 2004, Bull Chin Cancer, 17, 909
Chen WQ, 2008, Cancer Mortality Report of 34 Cancer Registries in China, 2004, China Cancer, 17, 913
Zhang SW, 2009, A report of cancer incidence and mortality from 34 cancer registries in China, 2005, China Cancer, 18, 973
Zhang SW, 2010, A report of cancer incidence and mortality from 34 cancer registries in china, 2006, China Cancer, 19, 356
Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat. World Population Prospects the 2008 Revision.2010. Available athttp://esa.un.org/unpp.
Parkin DM, 2003, Cancer in Africa: epidemiology and prevention, 268
United Nations. UN data a world of information: Total fertility rate. 2010. Available athttp://data.un.org/Data.aspx?d=PopDiv&f=variableID%3A54 (accessed on 15–3‐2010).
ZhaoFH XuLN HongY NiyaziM GaoXH JuLR ZhangLQ FengXX DuanXZ QiaoYL.A multi‐center survey on age of sexual debut in Chinese women: suggestions for optimal age of HPV vaccination in China. Presented at the 26th International Papillomavirus Conference and Clinical Workshop Montreal Canada 2010.722.
Xiao L, 2009, What is the prevalence of smoking in China, Zhonghua Liu Xing Bing Xue Za Zhi, 30, 30
Zhao FH, 2010, Cervical cancer mortality in 2004–2005 and changes during last 30 years in China, Zhonghua Yu Fang Yi Xue Za Zhi, 44, 408
QiaoYL FranceschiS BelinsonJL WeiLH XuAD LiCQ NiyaziM RenSD LiLK WuRF HuangRD SmithJS.HPV Prevalence in Chinese women: a population‐based multiple center survey in Mainland China. Presented at the 24th International Papillomavirus Conference and Clinical Workshop Beijing China 2007.